MedTrace Logo

Intravenous Treatment of Anemia in Pregnancy

NCT03317210 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2017-11-06

No results posted yet for this study

Summary

The investigators assess and compare the efficacy of anemia treatment in pregnant women with anemia of chronic disease with true iron deficiency and in women with iron deficiency anemia.

Conditions

Interventions

DRUG

iron sucrose (200 mg VENOFER®)

According to hemoglobin level at the start of the therapy, the women were either treated with intravenous iron and rhEPO or with intravenous iron only twice weekly.

DRUG

recombinant human erythropoietin (10,000 U EPREX®)

According to hemoglobin level at the start of the therapy, the women were treated with rhEPO twice weekly.

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Roland Zimmermann, Prof. · University of Zurich

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-09-01
Primary Completion
2006-07-31
Completion
2006-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03317210 on ClinicalTrials.gov